2021 Virtual Best of Breast


 

59 y/o Woman With HER2+ Invasive Ductal Carcinoma: Is Neoadjuvant Trastuzumab/Pertuzumab the Best Choice? How to Manage Pertuzumab-Induced Diarrhea?

0 views
January 21, 2021
Comments 0
Login to view comments. Click here to Login